$Minerva Neurosciences (NERV.US)$ (NASDAQ:NERV) are shooting...
(NASDAQ:NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via private placement of its shares, priced at a premium to the current levels.
Minerva has agreed to sell an aggregate of 1.43 million shares of its common stock at a purchase price of $10 per share and pre-funded warrants to purchase an aggregate of 575,575 shares at a purchase price of $9.99 per pre-funded warrant.
Minerva has agreed to sell an aggregate of 1.43 million shares of its common stock at a purchase price of $10 per share and pre-funded warrants to purchase an aggregate of 575,575 shares at a purchase price of $9.99 per pre-funded warrant.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
